STSeena Tabibi

Seena Tabibi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seena Tabibi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adrenal gland cytology reporting: a multi‐institutional proposal for a standardized reporting system

    by Levent Trabzonlu, Lucy Jager, Seena Tabibi, Margaret L. Compton, Vivian L. Weiss, Yonca Kanber, Valentina Robila, Tatjana Antic, Zahra Maleki, Elizabeth Morency, et al.

    BACKGROUND: With the development of new technologies and the changing patient profiles, cytopathology departments receive increasing numbers of adrenal gland cytology specimens. In this study, the authors analyzed archival adrenal gland cytology cases and attempted to implement a diagnostic reporting system.DESIGN: Retrospective electronic medical record search was performed for adrenal gland cytology specimens in seven tertiary care centers. The cytology diagnoses were grouped in 7 categories: nondiagnostic, nonneoplastic, benign adrenal cortical elements (BACE), primary neoplasm of noncortical origin (NONC), atypia of undetermined significance (AUS), suspicious for malignancy (SM), and malignant (MAL). If available, histopathology results of concurrent and/or follow‐up biopsies and/or resections were documented.RESULTS: A total of 473 adrenal gland cytology cases were included. BACE cases comprised 21.8%, whereas MAL cases were 57.5% of all cases. For BACE and MAL categories, there were 100% and 98.9% correlation, respectively, in the cases with histopathology follow‐up. Six of 10 NONC cases had histopathology diagnoses and there were 3 pheochromocytomas and 3 schwannomas. Twenty‐one AUS cases had histology follow‐up and 10 (47.6%) of them were malignant. Six cases of SM had histopathology follow‐up, and all of them were malignant on the follow‐up.CONCLUSIONS: The authors propose a 7‐tier diagnostic scheme for adrenal gland cytology. The risk of malignancy was 98.9% in MAL cases (87/88) in the cohort. The only case with discordance was reported as “adrenal cortical adenoma with marked atypia”' on resection. There was no difference between endoscopic ultrasound‐guided and percutaneous methods. Further studies are needed to validate and make this approach universal.;


  • Open Access

    Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients

    by Seena Tabibi, Tara Tabibi, Rosalynn R. Z. Conic, Nassim Banisaeed, Michael B. Streiff

    In the 5 months since initial reports of COVID-19 came to light, the death toll due to SARS-CoV-2 has rapidly increased. The morbidity and mortality of the infection varies based upon patient age, comorbid conditions, viral load, and the availability of effective treatments. Findings from limited autopsies, clinical observations, and laboratory data suggest that high cytokine levels and a procoagulant state can precipitate acute respiratory distress syndrome and multi-organ dysfunction syndrome in critically ill patients. To complicate matters, comorbidities may affect the response to medical treatments currently in use, all of which are still in trial phase. Therapeutic plasma exchange (TPE) merits consideration in the treatment of critically ill COVID-19 patients and is an avenue for clinical trials to pursue. If efficacious, faster recovery of patients may lead to shorter intensive care unit stays and less time on mechanical ventilation. Herein, we briefly discuss some of the various approaches currently being investigated for the treatment of SARS-CoV-2 with a focus on potential benefits of TPE for selected critically ill patients.